Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN). (Q44123201)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN). |
scientific article |
Statements
1 reference
Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN). (English)
1 reference
V S Moiseyev
1 reference
P Põder
1 reference
N Andrejevs
1 reference
M Y Ruda
1 reference
A P Golikov
1 reference
L B Lazebnik
1 reference
Z D Kobalava
1 reference
L A Lehtonen
1 reference
T Laine
1 reference
M S Nieminen
1 reference
K I Lie
1 reference
RUSSLAN Study Investigators
1 reference
1 September 2002
1 reference
1 reference
Identifiers
1 reference